• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    5/8/23 12:59:01 PM ET
    $ANIP
    $APM
    $BAK
    $BAOS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ANIP alert in real time by email

    Gainers

    • Trevena, Inc. (NASDAQ:TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China.
    • Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) jumped 139% to $0.9321. Bellicum Pharmaceuticals 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in the company.
    • Immuron Limited (NASDAQ:IMRN) climbed 62.9% to $3.0470 after the company announced the FDA removed the clinical hold on the New Campylobacter ETEC Therapeutic IND application.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) climbed 45.1% to $1.93 after jumping around 54% on Friday.
    • VCI Global Limited (NASDAQ:VCIG) gained 37% to $5.37.
    • EZFill Holdings Inc. (NASDAQ:EZFL) shares gained 28.8% to $2.86.
    • Ideanomics, Inc. (NASDAQ:IDEX) gained 28% to $0.0546 after the company’s subsidiary, US Hybrid, announced two contracts valued at over $6 million.
    • OKYO Pharma Limited (NASDAQ:OKYO) rose 28% to $2.22.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) jumped 27.4% to $3.0606 after posting a profit for the first quarter.
    • U.S. GoldMining Inc. (NASDAQ:USGO) climbed 25.8% to $12.99.
    • Innodata Inc. (NASDAQ:INOD) shares climbed 25.3% to $7.72. Innodata is expected to report Q1 results on May 11, 2023.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) gained 21.8% to $0.1338 after dropping 12% on Friday. Crown Electrokinetics recently issued a letter to shareholders.
    • Greenland Technologies Holding Corporation (NASDAQ:GTEC) gained 21.5% to $1.4575 after dropping around 8% on Friday.
    • fuboTV Inc. (NYSE:FUBO) rose 20% to $1.76. FuboTV recently reported better-than-expected Q1 financial results and raised FY23 guidance.
    • Six Flags Entertainment Corporation (NYSE:SIX) gained 20% to $26.97 after the company reported better-than-expected Q1 financial results.
    • Zscaler, Inc. (NASDAQ:ZS) gained 19.8% to $107.21 after the company said it expects to report Q3 revenue above its prior guidance.
    • Republic First Bancorp, Inc. (NASDAQ:FRBK) surged 18.9% to $0.8323.
    • Magic Empire Global Limited (NASDAQ:MEGL) rose 18.2% to $2.1401 after dropping over 11% on Friday.
    • Opendoor Technologies Inc. (NASDAQ:OPEN) gained 16.6% to $2.09. Keefe, Bruyette & Woods maintained Opendoor Technologies with an Underperform and raised the price target from $1.1 to $1.2.
    • ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) surged 16.2% to $45.49 following upbeat quarterly results.
    • Napco Security Technologies, Inc. (NASDAQ:NSSC) gained 15.2% to $31.55 following strong Q3 results.
    • Enviva Inc. (NYSE:EVA) gained 12% to $10.14. Enviva recently reported weak Q1 results.
    • Assure Holdings Corp. (NASDAQ:IONM) surged 11.7% to $2.57. Assure recently filed for an offering of up to 2 million shares of common stock.
    • Cue Health Inc. (NASDAQ:HLTH) jumped 11.5% to $0.8697. Cue Health reported an expansion of its Cue Integrated Care Platform to include a new pharmacy offering with over-the-counter and prescription medication options for a growing number of common health and wellness needs.
    • LSB Industries, Inc. (NYSE:LXU) rose 11.5% to $9.85. LSB Industries announced stock repurchase program authorization of up to $150 million.
    • Braskem S.A. (NYSE:BAK) shares gained 10.2% to $10.15. Braskem SA shares jumped over 20% on Friday following a report suggesting Apollo will offer up to $7.22B for the company.
    • HNI Corporation (NYSE:HNI) gained 10.1% to $27.77 following strong quarterly results.
    • Energizer Holdings, Inc. (NYSE:ENR) surged 6.3% to $34.79 after the company reported better-than-expected Q2 EPS and issued FY23 EPS guidance with a midpoint above estimates.

    Losers

    • Catalent, Inc. (NYSE:CTLT) shares fell 26.2% to $35.23 after the company announced it will be delaying the release of its Q3 results. The company said it expects to significantly reduce both its FY23 net revenue and adjusted EBITDA guidance by more than $400 million each.
    • Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) dropped 24.3% to $3.45.
    • Aptorum Group Limited (NASDAQ:APM) fell 24.3% to $4.05 after gaining 11% on Friday. Aptorum Group received Nasdaq notification of minimum stockholders’ equity deficiency.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) dipped 23.8% to $7.60.
    • Bit Origin Ltd (NASDAQ:BTOG) dropped 21.5% to $0.1798.
    • Tupperware Brands Corporation (NASDAQ:TUP) fell 21% to $0.8601. Tupperware filed non-timely 10-Q. The company identified additional prior period misstatements, additional material weaknesses in internal control over financial reporting.
    • Xinyuan Real Estate Co., Ltd. (NYSE:XIN) dropped 18% to $4.1798.
    • Tyson Foods, Inc. (NYSE:TSN) fell 15% to $51.61 as its second-quarter results missed Street expectations. The company also reduced its FY23 sales outlook.
    • Tredegar Corporation (NYSE:TG) dropped 14.6% to $8.04 after the company posted a decline in quarterly EPS.
    • LL Flooring Holdings, Inc. (NYSE:LL) fell 14.5% to $3.0350 after the company reported weaker-than-expected quarterly results.
    • Lyell Immunopharma, Inc. (NASDAQ:LYEL) dipped 12.7% to $2.1650.
    • Trupanion, Inc. (NASDAQ:TRUP) dropped 12.4% to $25.30. B of A Securities downgraded Trupanion from Buy to Neutral and lowered the price target from $72 to $32.
    • Bit Digital, Inc. (NASDAQ:BTBT) shares dropped 12.3% to $2.07. Bit Digital recently issued its unaudited bitcoin production and corporate updates for the month of April 2023.
    • Dunxin Financial Holdings Limited (NYSE:DXF) fell 12.2% to $0.23.
    • Nanobiotix S.A. (NASDAQ:NBTX) dipped 11.8% to $5.89.
    • Save Foods, Inc. (NASDAQ:SVFD) fell 11.7% to $1.06 after surging 53% on Friday.
    • Tenaya Therapeutics, Inc. (NASDAQ:TNYA) dropped 11.3% to $6.03.
    • Riot Platforms, Inc. (NASDAQ:RIOT) declined 11.3% to $10.23. Shares of several crypto-related stocks traded lower Monday amid a decline in the overall cryptocurrency market, led by Bitcoin.
    • MDJM Ltd (NASDAQ:MDJH) fell 10% to $2.35 after declining 5% on Friday.
    • Baijiayun Group Ltd (NASDAQ:RTC) dropped 9.9% to $6.52.
    • Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) fell 9.1% to $0.3710 after jumping over 37% on Friday. Galmed Pharmaceuticals recently entered into agreement for $1.5m equity investment in OnKai.
    • NantHealth, Inc. (NASDAQ:NH) fell 9% to $2.91 after jumping 33% on Friday.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) fell 9% to $9.55. Shares of several crypto-related stocks traded lower Monday amid a decline in the overall cryptocurrency market, led by Bitcoin.
    • Green Dot Corporation (NYSE:GDOT) dropped 8.2% to $17.26. Needham downgraded Green Dot from Buy to Hold.
    • Minim, Inc. (NASDAQ:MINM) fell 7.6% to $4.24 after jumping 61% on Friday.
    • CleanSpark, Inc. (NASDAQ:CLSK) shares fell 6.1% to $3.9431 amid a decline in the prices of Bitcoin and Ethereum.

    Now Read This: US Stocks Edge Lower; Tyson Foods Posts Q2 Loss

    Get the next $ANIP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ANIP
    $APM
    $BAK
    $BAOS

    CompanyDatePrice TargetRatingAnalyst
    FuboTV Inc.
    $FUBO
    3/27/2026$18.00Buy
    B. Riley Securities
    Tyson Foods Inc.
    $TSN
    3/26/2026$72.00Outperform
    Mizuho
    Braskem SA ADR
    $BAK
    3/26/2026$2.80Neutral → Underperform
    BofA Securities
    Lyell Immunopharma Inc.
    $LYEL
    3/9/2026$34.00Mkt Outperform
    Citizens
    Zscaler Inc.
    $ZS
    3/3/2026$200.00Overweight
    Wells Fargo
    MARA Holdings Inc.
    $MARA
    2/27/2026Buy → Neutral
    H.C. Wainwright
    Zscaler Inc.
    $ZS
    2/27/2026$315.00 → $210.00Outperform
    BMO Capital Markets
    OKYO Pharma Limited
    $OKYO
    2/20/2026$7.00Overweight
    Piper Sandler
    More analyst ratings

    $ANIP
    $APM
    $BAK
    $BAOS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 6, 2023 - FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process

    For Immediate Release: June 06, 2023 Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in nasal swabs from adults with signs and symptoms of upper respiratory infection. This test is the first at-home over-the-c

    6/6/23 3:04:14 PM ET
    $HLTH
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    FDA Approval for HYDROCODONE BITARTRATE AND IBUPROFEN

    Submission status for ANI PHARMS INC's drug HYDROCODONE BITARTRATE AND IBUPROFEN (SUPPL-6) with active ingredient HYDROCODONE BITARTRATE; IBUPROFEN has changed to 'Approval' on 03/04/2021. Application Category: ANDA, Application Number: 077454, Application Classification: Labeling

    3/8/21 5:11:24 AM ET
    $ANIP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OXYCODONE AND ASPIRIN

    Submission status for ANI PHARMS INC's drug OXYCODONE AND ASPIRIN (SUPPL-30) with active ingredient ASPIRIN; OXYCODONE HYDROCHLORIDE; OXYCODONE TEREPHTHALATE has changed to 'Approval' on 03/04/2021. Application Category: ANDA, Application Number: 040255, Application Classification: Labeling

    3/8/21 5:11:06 AM ET
    $ANIP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANIP
    $APM
    $BAK
    $BAOS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on fuboTV with a new price target

    B. Riley Securities initiated coverage of fuboTV with a rating of Buy and set a new price target of $18.00

    3/27/26 8:48:55 AM ET
    $FUBO
    Movies/Entertainment
    Consumer Discretionary

    Mizuho initiated coverage on Tyson Foods with a new price target

    Mizuho initiated coverage of Tyson Foods with a rating of Outperform and set a new price target of $72.00

    3/26/26 8:52:50 AM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    Braskem SA downgraded by BofA Securities with a new price target

    BofA Securities downgraded Braskem SA from Neutral to Underperform and set a new price target of $2.80

    3/26/26 8:40:27 AM ET
    $BAK
    Major Chemicals
    Industrials

    $ANIP
    $APM
    $BAK
    $BAOS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Arch Venture Partners Ix, Llc bought $12,499,985 worth of shares (488,090 units at $25.61) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    3/9/26 4:36:20 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Arch Venture Fund Xiii, L.P. bought $12,499,985 worth of shares (488,090 units at $25.61) (SEC Form 4)

    4 - Lyell Immunopharma, Inc. (0001806952) (Issuer)

    3/9/26 4:34:54 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Aqua Capital, Ltd. bought $112,360 worth of shares (5,000 units at $22.47), increasing direct ownership by 0.07% to 7,005,000 units (SEC Form 4)

    4 - ENERGIZER HOLDINGS, INC. (0001632790) (Issuer)

    3/3/26 4:15:47 PM ET
    $ENR
    Industrial Machinery/Components
    Miscellaneous

    $ANIP
    $APM
    $BAK
    $BAOS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Zhu Justin

    4 - Bit Digital, Inc (0001710350) (Issuer)

    3/27/26 9:21:21 PM ET
    $BTBT
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Tabar Samir

    4 - Bit Digital, Inc (0001710350) (Issuer)

    3/27/26 9:21:01 PM ET
    $BTBT
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Huang Erke

    4 - Bit Digital, Inc (0001710350) (Issuer)

    3/27/26 9:20:42 PM ET
    $BTBT
    Finance: Consumer Services
    Finance

    $ANIP
    $APM
    $BAK
    $BAOS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

    PARIS and CAMBRIDGE, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ:NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 31st, 2026, after the close of the U.S. market. This release will be followed by a conference call and webcast on Wednesday, April 1st, 2026, at 8:00 AM EDT / 2:00 PM CEST, prior to the open of the U.S. market. During the call, Laurent Levy, chief executive office

    3/26/26 4:15:00 PM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MARA Holdings, Inc. Announces $1.0 Billion Repurchase of 0.00% Convertible Senior Notes due 2030 and 2031 and Sale of 15,133 Bitcoin

    Miami, FL, March 26, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ:MARA) ("MARA" or the "Company"), a leading digital energy and infrastructure company, today announced that it has entered into privately negotiated repurchase agreements with certain holders of its outstanding 0.00% Convertible Senior Notes due 2030 (the "2030 Notes") and 0.00% Convertible Senior Notes due 2031 (the "2031 Notes" and, together with the 2030 Notes, the "Notes") to repurchase approximately $367.5 million in aggregate principal amount of the 2030 Notes for an aggregate cash repurchase price of approximately $322.9 million and approximately $633.4 million in aggregate principal amount of the 2031 Notes fo

    3/26/26 8:05:00 AM ET
    $MARA
    EDP Services
    Technology

    NANOBIOTIX Statement Regarding Recent Media Speculation

    PARIS and CAMBRIDGE, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today issued the following statement in response to recent media speculation concerning intentions for a potential public take-over. Nanobiotix states that, to the best of its knowledge, there is no such intention to acquire control of the Company, and no process or assessment is being conducted toward that end. Additionally, the Company has identified factual inaccuracies in this media report which are not consistent with the Company's

    3/25/26 10:11:21 AM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ANIP
    $APM
    $BAK
    $BAOS
    SEC Filings

    View All

    SEC Form 6-K filed by Braskem SA ADR

    6-K - BRASKEM SA (0001071438) (Filer)

    3/27/26 4:34:16 PM ET
    $BAK
    Major Chemicals
    Industrials

    SEC Form 10-K filed by Bit Digital Inc.

    10-K - Bit Digital, Inc (0001710350) (Filer)

    3/27/26 4:30:29 PM ET
    $BTBT
    Finance: Consumer Services
    Finance

    SEC Form S-3 filed by Greenland Technologies Holding Corporation

    S-3 - Greenland Technologies Holding Corp. (0001735041) (Filer)

    3/27/26 4:15:28 PM ET
    $GTEC
    Industrial Machinery/Components
    Industrials

    $ANIP
    $APM
    $BAK
    $BAOS
    Financials

    Live finance-specific insights

    View All

    NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026

    PARIS and CAMBRIDGE, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ:NBTX – the ‘‘Company''), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major diseases, announced today that it will report its financial results for the fourth quarter and full year ended December 31, 2025, on Tuesday, March 31st, 2026, after the close of the U.S. market. This release will be followed by a conference call and webcast on Wednesday, April 1st, 2026, at 8:00 AM EDT / 2:00 PM CEST, prior to the open of the U.S. market. During the call, Laurent Levy, chief executive office

    3/26/26 4:15:00 PM ET
    $NBTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Bit Digital, Inc. Announces Date for Fourth Quarter and Fiscal Year 2025 Financial Results and Conference Call

    NEW YORK, March 24, 2026 /PRNewswire/ -- Bit Digital, Inc. (NASDAQ:BTBT) ("Bit Digital" or the "Company") today announced that it will release its financial results for the fourth quarter and fiscal year 2025, after the market closes on Tuesday, March 31, 2026. Senior management will host a live webcast and conference call to discuss the results at 10:00 a.m. Eastern Time on Wednesday, April 1, 2026.To register for the webcast, please click here. Participants may also join the conference call by dialing 1-800-330-6730 (passcode: 832471).The earnings press release will be availab

    3/24/26 8:00:00 AM ET
    $BTBT
    $WYFI
    Finance: Consumer Services
    Finance

    OKYO Pharma Announces Chairman and Founder Acquires Shares

    LONDON and NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced it has been informed that Panetta Partners Limited, an entity in which Gabriele Cerrone, the Executive Chairman, has a beneficial interest, has acquired 10,119 of the Company's ordinary shares on NASDAQ at $1.59, bringing his total holding to 10,526,416 shares. About Urcosimod (formerly called OK-101) Urcosimod is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor which is typically

    3/19/26 12:00:00 PM ET
    $OKYO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ANIP
    $APM
    $BAK
    $BAOS
    Leadership Updates

    Live Leadership Updates

    View All

    Lyell Immunopharma Reports Q4 and Full Year 2025 Business and Financial Results

    Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal trial (PiNACLE) evaluating ronde-cel is ongoingPhase 1 trial is ongoing for LYL273, an enhanced GCC-targeted CAR T-cell candidate for metastatic colorectal cancer; seven new patients treated without dose-limiting toxicity and including dose escalation to Dose Level 3Smital Shah was appointed Chief Financial and Business Officer in March 2026Second $50 million tranche of $100 million equity private placement closed in March 2026 after achievement of clinical milestone for ronde-celCash of approximate

    3/12/26 4:05:00 PM ET
    $LYEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vertiv Holdings, Lumentum Holdings, Coherent, and EchoStar Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600

    NEW YORK, March 6, 2026 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices: NAPCO Security Technologies Inc. (NASD: NSSC) will replace Alexander & Baldwin Inc. (NYSE:ALEX) in the S&P SmallCap 600 effective prior to the opening of trading on Friday, March 13. An investor group comprised of MW Group and funds affiliated with DivcoWest and Blackstone Real Estate is acquiring Alexander & Baldwin in a deal that is expected to close soon, pending final closing conditions.The following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 will take effect before the market opens on M

    3/6/26 6:39:00 PM ET
    $AGX
    $AHRT
    $AIG
    Engineering & Construction
    Consumer Discretionary
    Real Estate
    Finance

    U.S. GoldMining Appoints Imola Götz as VP, Project Development

    ANCHORAGE, Alaska, March 5, 2026 /CNW/ - U.S. GoldMining Inc. (NASDAQ:USGO) ("U.S. GoldMining" or the "Company") is pleased to announce the appointment of Imola Götz as Vice President, Project Development. Ms. Götz is a veteran mining engineer with over 30 years of international experience in both open-pit and underground mining environments including in world renowned gold mining camps of Hemlo and Timmins. Ms. Gotz is an expert in developing life of mine plans, strategic business plans, and comparative economic evaluations of mining projects, developed over decades of experien

    3/5/26 6:30:00 AM ET
    $USGO
    Precious Metals
    Basic Materials

    $ANIP
    $APM
    $BAK
    $BAOS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by VCI Global Limited

    SC 13G - VCI Global Ltd (0001930510) (Subject)

    12/6/24 6:01:22 AM ET
    $VCIG
    Diversified Commercial Services
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Innodata Inc.

    SC 13D/A - INNODATA INC (0000903651) (Subject)

    11/26/24 5:19:30 PM ET
    $INOD
    EDP Services
    Technology

    Amendment: SEC Form SC 13D/A filed by Minim Inc.

    SC 13D/A - MINIM, INC. (0001467761) (Subject)

    11/15/24 5:00:07 PM ET
    $MINM
    Telecommunications Equipment
    Utilities